Cargando…

Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response

A low response rate limits the application of immune checkpoint inhibitors (ICIs) in the treatment of esophageal adenocarcinoma (EAC), which requires the precise characterization of heterogeneous tumor microenvironments. This study aimed to identify the molecular features and tumor microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ling, Chen, Zhou, Xiuman, Gao, Yanfeng, Sui, Xinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144862/ https://www.ncbi.nlm.nih.gov/pubmed/35631431 http://dx.doi.org/10.3390/ph15050605

Ejemplares similares

A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8(+) T cell responses
por: Zhai, Wenjie, et al.
Publicado: (2020)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses
por: Li, Yimin, et al.
Publicado: (2021)

Identification of Aging and Young Subtypes for Predicting Colorectal Cancer Prognosis and Immunotherapy Responses
por: Tan, Lulu, et al.
Publicado: (2023)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma
por: Sui, Xinghua, et al.
Publicado: (2023)

Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
por: Sun, Zihao, et al.
Publicado: (2023)

A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Tang, Xiaolong, et al.
Publicado: (2022)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

Identification of mitochondrial respiratory chain signature for predicting prognosis and immunotherapy response in stomach adenocarcinoma
por: Yang, Jing, et al.
Publicado: (2023)

Identification of HLA-A2-Restricted Mutant Epitopes from Neoantigens of Esophageal Squamous Cell Carcinoma
por: Wang, Zhiwei, et al.
Publicado: (2021)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR
por: Zhou, Xiuman, et al.
Publicado: (2020)

Immune checkpoint PTPN2 predicts prognosis and immunotherapy response in human cancers
por: Tang, Xiaolong, et al.
Publicado: (2023)

Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer
por: Cao, Kui, et al.
Publicado: (2021)

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma
por: Yang, Chuang, et al.
Publicado: (2023)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction
por: Meng, Qingqing, et al.
Publicado: (2020)

Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma
por: Gao, Yukui, et al.
Publicado: (2022)

A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma
por: Gong, Wei-Jing, et al.
Publicado: (2021)

Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses
por: Chen, Yu-Pei, et al.
Publicado: (2021)

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma
por: Li, Shaowen, et al.
Publicado: (2021)

Prediction of Prognosis in Patients with Hepatocellular Carcinoma Based on Molecular Subtypes of Immune Genes
por: Du, Suming, et al.
Publicado: (2022)

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
por: Wang, Hongfei, et al.
Publicado: (2020)

Identification and validation of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with lung adenocarcinoma
por: Li, Chunhong, et al.
Publicado: (2023)

Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients
por: Luo, Ting, et al.
Publicado: (2022)

The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma
por: Zhuo, Xingxing, et al.
Publicado: (2022)

Identification of Factors for the Preoperative Prediction of Tumour Subtype and Prognosis in Patients with T1 Lung Adenocarcinoma
por: Zhu, Wang-Yu, et al.
Publicado: (2016)

Discovery of a novel dual-targeting D-peptide to block CD24/Siglec-10 and PD-1/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy
por: Shen, Wenhui, et al.
Publicado: (2023)

Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer
por: Ko, Kyung-Pil, et al.
Publicado: (2023)

Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma
por: Liu, Qian, et al.
Publicado: (2021)

Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction
por: Hu, Xin, et al.
Publicado: (2021)

Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
por: Jia, Ran, et al.
Publicado: (2021)

Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma
por: Liu, Zi-Tao, et al.
Publicado: (2023)

Identification of bladder cancer subtypes and predictive model for prognosis, immune features, and immunotherapy based on neutrophil extracellular trap-related genes
por: Guo, Changhong, et al.
Publicado: (2023)

Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer
por: Wang, Xinjing, et al.
Publicado: (2021)

DNA damage repair molecular subtype derived immune signature applicable for the prognosis and immunotherapy response prediction in colon cancer
por: Shang, Zhen, et al.
Publicado: (2023)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qfuolsb9bs451s4bjjjkqe9cio